We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GAP:NYSEGap, Inc. (The) Analysis

Data as of 2026-05-19 - not real-time

$20.73

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Gap’s price sits at $20.73, just above the computed support of $20.55 and below its 20‑day ($23.61) and 50‑day ($24.28) SMAs, indicating a bearish price trend. Technical momentum is weak – the MACD line is negative and below its signal line, the histogram is shrinking, and the 14‑day RSI at 28.6 signals an oversold condition that could spark a short‑term bounce. The stock trades slightly above its DCF‑derived fair value of $20.14, with a low trailing PE of 9.7 and a solid dividend yield of 3.38%, suggesting current pricing is roughly fair but not deeply discounted. However, the 30‑day volatility of 41% and beta above 1.3 point to heightened market risk, while the “Extreme Greed” sentiment index (89.6) hints that investors may be overly optimistic despite modest revenue growth (2.1%).
Fundamentally, Gap delivers steady cash generation (operating cash flow $1.29B, free cash flow $0.70B) and a comfortable payout ratio (~30%). The balance sheet shows a high debt‑to‑equity ratio (~148%), but ample cash offsets immediate liquidity concerns. The dividend appears sustainable, and the consensus analyst rating is a “Buy” with a mean target price near $30.6, implying potential upside if the company can sustain margin improvements and navigate tariff risks noted in recent coverage.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Oversold RSI suggests near‑term price rebound
  • Price hovering just above support level
  • Increasing volume indicates buying interest

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Bearish SMA alignment (price below 20‑day and 50‑day SMAs)
  • Modest revenue growth and margin improvement constraints
  • Elevated volatility and beta increasing market sensitivity

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend yield of 3.38% with low payout ratio
  • Strong cash flow generation supporting dividend continuity
  • Fundamental valuation near fair value with upside potential per analyst targets

Key Metrics & Analysis

Financial Health

Revenue Growth2.10%
Profit Margin5.31%
P/E Ratio9.7
ROE23.10%
ROA5.62%
Debt/Equity147.62
P/B Ratio2.0
Op. Cash Flow$1.3B
Free Cash Flow$701.2M

Technical Analysis

TrendBearish
RSI28.6
Support$20.55
Resistance$27.95
MA 20$23.61
MA 50$24.28
MA 200$24.44
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$20.14
Target Price$30.56
Upside/Downside47.44%
GradeFair
TypeValue
Dividend Yield3.38%

Risk Assessment

Beta1.34
Volatility41.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.